Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomallei

21 Jul 2014

Abstract excerpt

Sir, With the recent publication of the MERTH study [1], trimethoprim/sulfamethoxazole (SXT) monotherapy will be used increasingly in the treatment of melioidosis during the eradication phase, and possibly as the only treatment for some mild infections. It is therefore important to know the prevalence of SXT resistance in Burkholderia pseudomallei. This is difficult to test in vitro, with disc diffusion...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Burkholderia infections and melioidosis

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 25245211
DOI: 10.1016/j.ijantimicag.2014.06.003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Trimethoprim/sulfamethoxazole resistance in Burkholderia pseudomalleiPMID 25245211Read ↗

Development of ceftazidime resistance in an acute Burkholderia pseudomallei infectionSemantic proximity Read ↗

Mechanisms of Resistance to Folate Pathway Inhibitors in Burkholderia pseudomallei: Deviation from the Norm.Semantic proximity Read ↗

Meropenem resistant Burkholderia pseudomallei - A concerning single case in Australia with no prior meropenem exposureSemantic proximity Read ↗

Multilocus sequence typing of clinical Burkholderia pseudomallei isolates from Cambodia.Semantic proximity Read ↗

Emergence of ceftazidime resistance in Burkholderia pseudomallei during therapy: Clinical, phenotypic and genotypic insights from paired isolates.Semantic proximity Read ↗

The BpeEF-OprC Efflux Pump Is Responsible for Widespread Trimethoprim Resistance in Clinical and Environmental Burkholderia pseudomallei IsolatesSemantic proximity Read ↗

Evaluation of the Antibacterial Activity of Piperacillin–tazobactam Against Burkholderia Pseudomallei in VitroSemantic proximity Read ↗

Mechanisms of Antibiotic Resistance in <i>Burkholderia Pseudomallei</i> : Implications for Treatment of MelioidosisSemantic proximity Read ↗

Meropenem-resistant Burkholderia pseudomallei: a concerning single case in Australia with no prior meropenem exposureSemantic proximity Read ↗

Burkholderia pseudomallei Isolates from Sarawak, Malaysian Borneo, Are Predominantly Susceptible to Aminoglycosides and MacrolidesSemantic proximity Read ↗

Evolutionary Convergence on a Dihydrofolate Reductase Mutation Drives Trimethoprim-Sulfamethoxazole Resistance in Burkholderia thailandensis.Semantic proximity Read ↗

Assessment of trimethoprim-sulfamethoxazole susceptibility testing methods for fastidious Haemophilus spp.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.